Literature DB >> 1617339

Churg-Strauss syndrome.

J G Lanham1.   

Abstract

The presentation of Churg-Strauss syndrome is most distinctive, permitting diagnosis on clinical grounds. It is a phasic disorder with allergic rhinitis and asthma initially, often followed by peripheral blood eosinophilia with eosinophilic tissue infiltrates. The vasculitic illness is the life-threatening phase, but it can be effectively suppressed by prompt treatment.

Entities:  

Mesh:

Year:  1992        PMID: 1617339

Source DB:  PubMed          Journal:  Br J Hosp Med        ISSN: 0007-1064


  7 in total

1.  Churg-Strauss syndrome.

Authors:  P Ramnarayan; S Sowmya; N Biswal; P Nalini; C Ratnakar
Journal:  Indian J Pediatr       Date:  1998 May-Jun       Impact factor: 1.967

2.  Churg-Strauss syndrome occurring during omalizumab treatment.

Authors:  Muhammed Bekçibaşı; Sezgin Barutçu; Mustafa Kemal Çelen; Saim Dayan; Salih Hoşoğlu
Journal:  Eur J Rheumatol       Date:  2015-03-31

3.  Churg-Strauss syndrome: the clinical features and long-term follow-up of 17 patients.

Authors:  Mi Jung Oh; Jin Young Lee; Nam Hee Kwon; Dong Chull Choi
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

4.  Multi-system mitochondrial disorder with recurrent steroid-responsive eosinophilia.

Authors:  Josef Finsterer; Franz Höger
Journal:  Rheumatol Int       Date:  2009-11       Impact factor: 2.631

5.  Carbimazole-induced lupus.

Authors:  Ihteshamul Haq; Michael D Sosin; Simon Wharton; Anindya Gupta
Journal:  BMJ Case Rep       Date:  2013-02-06

6.  Churg-strauss syndrome in the pediatric age group.

Authors:  Yehia El-Gamal
Journal:  World Allergy Organ J       Date:  2008-02       Impact factor: 4.084

7.  Dysphonia and dyspnea in idiopathic hypereosinophilic syndrome treated with Mepolizumab.

Authors:  Dana Kay; Ali Ataya; Xiuli Liu; Jena Auerbach; Dan Urbine
Journal:  Respir Med Case Rep       Date:  2018-05-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.